Healthcare, Life Sciences and Pharma risk and risk management

Healthcare Life Sciences Pharma

Regulators are cracking down on PFAS and risk managers must plan accordingly

The effects of PFAS chemicals are yet to be seen as health problems slowly come to light. BHSI’s Javier Villalba, explores the litigation landscape risk managers are facing

Spotlight on: bird flu and the risk it could spread to humans

The FAO, the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH) are urging countries to work together across sectors to prevent the spread of bird flu

How to manage reshoring risks - a US case study

Former pharma risk manager and current P.E. integrated risk leader at Sigma7, Andrew Tait, looks at how reshoring changes the exposures faced by manufacturing companies in the US, and what global lessons can be learnt

Learning lessons from pharma risk management

Kathrin Anne Meier, Board Member, SRA - Swiss Risk Association, explores how risk managers are tackling the unique threats facing the pharmaceutical industry and what other sectors can learn from their approach

Is risk getting enough attention in the NHS?

The potential for ”unintended consequences” is high as healthcare systems become more complex - BMJ

Digital health sector overexposed - survey

More than two thirds lack insurance coverage for bodily injury claims arising from system failure or cyber breach

Healthcare leads data risk assessments – Trustwave study

UK professionals value their personally identifiable data at less than half as much as their US counterparts, according to a report from tech firm Trustwave

Germany exempted from mandatory rebates for pharmaceutical companies

The European Commission found that the scheme pursues an objective of common interest

Healthcare in Africa improves amid Ebola outbreak

International SOS’ analysis reveals the world’s most dangerous locations concerning health risk